J Korean Med Sci.  2015 Jun;30(6):673-675. 10.3346/jkms.2015.30.6.673.

Reporting Results of Research Involving Human Subjects: An Ethical Obligation

Affiliations
  • 1JW LEE Center for Global Medicine, Seoul, Korea.
  • 2Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • 3Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul, Korea. hst@snu.ac.kr

Abstract

Researchers have an ethical responsibility to report the results of research involving human subjects. Dissemination of results ensures that patient care is based on good science and that the field of medicine advances based on complete and accurate knowledge. However, current evidence suggests that publication is often neglected or substantially delayed, especially in the case of negative and inconclusive results. Researchers, editors and reviewers should value all high-quality research regardless of the conclusiveness of the results and ensure that all research involving human subjects is registered in a publicly accessible database.

Keyword

Ethics, Research; Results Reporting; Negative Results; Trial Registration

MeSH Terms

Clinical Trials as Topic/*ethics
*Ethics, Research
Human Experimentation/*ethics
Publishing/*ethics
Republic of Korea
*Research Report
Research Subjects

Reference

1. World Medical Association. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. accessed on 5 December 2014. Available at http://www.wma.net/en/30publications/10policies/b3/.
2. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical. JAMA. 2000; 283:2701–2711.
3. World Medical Association. Declaration of Helsinki. accessed on 5 December 2014. Available at http://www.wma.net/en/20activities/10ethics/10helsinki/.
4. Christie B. Doctors revise declaration of Helsinki. BMJ. 2000; 321:913.
5. Human D, Fluss SS. The World Medical Association's Declaration of Helsinki: Historical and Contemporary Perspecitves. accessed on 5 December 2014. Available at http://www.wma.net/en/20activities/10ethics/10helsinki/draft_historical_contemporary_perspectives.pdf.
6. Journal of Korean Medical Science. Information for Contributors. accessed on 5 December 2014. Available at http://jkms.org/index.php?main=instruction.
7. Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ. 2013; 347:f6104.
8. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ. 2012; 344:d7292.
9. Manzoli L, Flacco ME, D'Addario M, Capasso L, De Vito C, Marzuillo C, Villari P, Ioannidis JP. Non-publication and delayed publication of randomized trials on vaccines: survey. BMJ. 2014; 348:g3058.
10. Blümle A, Meerpohl JJ, Schumacher M, von Elm E. Fate of clinical research studies after ethical approval: follow-up of study protocols until publication. PLoS One. 2014; 9:e87184.
11. Suñé P, Suñé JM, Montoro JB. Positive outcomes influence the rate and time to publication, but not the impact factor of publications of clinical trial results. PLoS One. 2013; 8:e54583.
12. Liebeskind DS, Kidwell CS, Sayre JW, Saver JL. Evidence of publication bias in reporting acute stroke clinical trials. Neurology. 2006; 67:973–979.
13. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008; 358:252–260.
14. Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics. 2012; 90:891–904.
15. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. accessed on 10 February 2014. Available at http://www.icmje.org/icmje-recommendations.pdf.
16. International Committee of Medical Journal Editors. Clinical Trial Registration. accessed on 5 December 214. Available at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html.
17. World Health Organization. Why is trial registration important? accessed on 5 December 2014. Available at http://www.who.int/ictrp/trial_reg/en/.
18. Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med. 2013; 10:e1001566. discussion e.
19. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database: update and key issues. N Engl J Med. 2011; 364:852–860.
20. Journal of Pharmaceutical Negative Results. accessed on 5 December 2014. Available at http://www.pnrjournal.com/.
21. Journal of Negative Results in Biomedicine. accessed on 5 December 2014. Available at http://www.jnrbm.com/.
22. Kundoor V, Mueen AK. Uncovering negative results: introducing an open access journal "journal of pharmaceutical negative results". J Young Pharm. 2010; 2:339–341.
23. Dirnagl U, Lauritzen M. Fighting publication bias: introducing the Negative Results section. J Cereb Blood Flow Metab. 2010; 30:1263–1264.
24. CRIS. About the Clinical Research Information Service (CRIS). accessed on 5 December 2014. Available at https://cris.nih.go.kr/cris/en/use_guide/cris_introduce.jsp.
25. Call for public consultation: WHO Statement on Public Disclosure of Clinical Trial Results 2014. accessed on 5 December 2014. Available from: http://www.who.int/ictrp/results/en/.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr